Elimination of Federal Diversity Initiatives: Updates and Current Status

• by Latoya Hill, Samantha Artiga

• June 4, 2026

How Quickly Are Patients Reaching Quadruple HFrEF Therapy?

Delays in initiating guideline-directed quadruple therapy may increase early clinical risk in heart failure with reduced ejection fraction.

• by Kathryn Wighton

• June 8, 2026

• 5 min

Chemoimmunotherapy Linked to HNSCC Response

Higher pathologic response rates with chemoimmunotherapy versus immunotherapy alone call for phase 3 trials, but survival implications remain unknown.

• by Andrea Surnit

• June 5, 2026

• 6 min

A novel nutritional tool to identify infants at risk of stunting

• by Qian Wei, Dandan Su, Jihong Wei, Yaowu Zhan

• June 8, 2026